Recognize Signs for Aflibercept in Wet AMD
Macular degeneration, predominantly affecting those aged 50 and above, manifests as either dry or the more severe wet form, risking rapid central vision loss. Aflibercept therapy emerges as a pivotal treatment for wet AMD, mitigating abnormal blood vessel growth and vision impairment. Understanding its application and benefits unveils a vital pathway in managing eye health. […]
3 minute read